Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

t is being prepared.

?These three Phase II clinical trials sponsored by NCI are components of a clinical trials program designed to identify signals of clinical activity of ispinesib across multiple tumor types,? stated Dr. Andrew A. Wolff, Cytokinetics Senior Vice President of Clinical Research and Development and Chief Medical Officer. ?Although these three trials did not meet the protocol-specified criteria for progression, we are encouraged by the anti-cancer activity of ispinesib observed to date in three other Phase II trials in breast, ovarian and non-small cell lung cancers. Based on these data, we plan to move forward in further clinical development of ispinesib with a focused approach to the potential treatment of breast cancer with ispinesib.?

Clinical Trials of Ispinesib

Ispinesib has been the subject of a broad Phase II clinical trials program under the sponsorship of GlaxoSmithKline (GSK) and is also being developed in collaboration with the NCI. GSK has sponsored three Phase II clinical trials, one evaluating ispinesib as second- or third-line treatment for patients with locally advanced or metastatic breast cancer, one evaluating ispinesib as second-line treatment for patients with non-small cell lung cancer, and one evaluating ispinesib as second-line treatment for patients with advanced ovarian cancer. Enrollment in all of these trials has been closed. To date, clinical activity with ispinesib has been observed in breast cancer, in non-small cell lung cancer, and ovarian cancer with the more robust clinical activity observed in a Phase II clinical trial evaluating ispinesib in the treatment of metastatic breast cancer patients that have failed treatment with taxanes and anthracyclines. In this clinical trial, The best overall responses observed with ispinesib were partial responses in 4 of 45 evaluable patients as measured by the RECIST criteria. Responses were confirmed by independent radiology review and were seen in
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:10/27/2014)... , Oct. 27, 2014  In the last few weeks, ... Africa to a worldwide crisis when a ... the virus and died, and two nurses were infected. ... could happen, the use of modern technology, such as electronic health ... unnoticed. This week, InformationWeek Healthcare Editor Alison Diana ...
(Date:10/27/2014)...  OMNIlife science™, Inc. ("OMNI™"), an established medical technology company ... market, announced it will exhibit its, navigated robotic system, ... of Hip and Knee Surgeons (AAHKS) 24th Annual Meeting ... Texas on November 6-9 in Booth #613. ... George B. Cipolletti , President and ...
(Date:10/27/2014)... At the American College of Emergency Physicians ... October 27-30, 2014, Mindray announces the new M9 premium ... technology. A powerful, versatile, and mobile system, the M9 ... for immediate clinical management and decision-making. ... emergency and critical care medicine has a significant impact ...
Breaking Medicine Technology:EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 2OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 3Mindray Introduces Premium Point-of-Care Ultrasound System at ACEP 2
... Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) announced today that it has ... regained compliance with the $1.00 minimum bid price requirement for continued ... , , ... Company that the bid price of its common stock had closed at less ...
... 26 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today that ... on the drugs in Isis, development pipeline.  The second call of the series ... April 28, 2010 at 12:00 p.m. ET .  This call will ... , , ...
Cached Medicine Technology:Catalyst Pharmaceutical Partners Regains Compliance with NASDAQ Minimum Bid Price Rule 2Isis Pharmaceuticals to Discuss Its Metabolic Franchise in a Conference Call on Wednesday, April 28 2Isis Pharmaceuticals to Discuss Its Metabolic Franchise in a Conference Call on Wednesday, April 28 3
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, ... genes have been identified that appear linked to autism ... say they are on their way to discovering up ... disorder. Autism spectrum disorders include a range of ... repetitive behaviors. An estimated one in 68 U.S. children ...
(Date:10/30/2014)... FL (PRWEB) October 30, 2014 ... offering therapeutic horseback riding to special needs individuals in ... Round-Up on Saturday, November 15 from 10-2:00 p.m. at ... event is open to the public and is designed ... , Admission to the HSS Round-Up is free. ...
(Date:10/30/2014)... The human brain is often overlooked ... to help maintain better mental health, according to Dr. ... Lose Your Memory in 100 Ways’ for just that ... conflicting attitudes to help keep the reader constantly thinking. ... must decipher the hidden logic within. , “If you ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- When it comes ... likely than men to delay care when they have symptoms ... someone comes to the hospital with a more severe or ... options available," study author Catherine Kreatsoulas, a Fulbright Scholar and ... in a news release from the Heart and Stroke Foundation ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- Many ... near campus, even though tanning increases the risk ... popular among young adults, particularly white women, so ... students, health, the researchers said. "Public health ... student population awareness of the harms that indoor ...
Breaking Medicine News(10 mins):Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... A University of Missouri researcher has found that ... increases satiety and reduces hunger throughout the day. In ... found that eating a protein-rich breakfast reduces the brain ... "Everyone knows that eating breakfast is important, but many ...
... reduced inflammation in Crohn,s patients in a research ... Crohn,s disease is a chronic inflammatory condition of ... bleeding and weight loss. Treatments for Crohn,s disease ... be associated with rare but serious side effects, ...
... studies on whether moderate exercise can curb the nicotine ... apparent contradiction: it seems to work in short-term, well ... trials. A new study may explain why and help ... in the results of research led by David Williams, ...
... little more difficult now that French researchers have discovered ... seriously compromised during long-term space flight. In a new ... ( http://www.fasebj.org ), the scientists show that antibodies produced ... terra firma. The reduced effectiveness of antibodies makes astronauts ...
... is a major problem for society behind only headaches as ... degeneration of the intervertebral disc. Researchers have worked for many ... on the lower back. Now, in results published in ... permanently replace the workings of the invertebral disc. It is ...
... , THURSDAY, May 19 (HealthDay News) -- Problem ... availability, especially online, of gambling opportunities, said experts who ... of the disorder. While most people gamble as ... become too seriously involved in terms of time invested ...
Cached Medicine News:Health News:Eat a protein-rich breakfast to reduce food cravings, prevent overeating later, researcher finds 2Health News:Use of naltrexone reduces inflammation in Crohn's patients 2Health News:Exercise helps women fight smoking cravings, but effect is short-lived 2Health News:Antibody production gets confused during long-term spaceflight 2Health News:Implant jab could solve the misery of back pain 2Health News:Internet Is Playing a Part in Spread of Problem Gambling 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: